Mark E. Ross, Dmd, Pa Dentist Medicare: Not Enrolled in Medicare Practice Location: 503 S Green St, Morganton, NC 28655 Phone: 828-439-9197 |
David A. Panzer Dds Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 343 Sanford Dr, Morganton, NC 28655 Phone: 828-430-4500 Fax: 828-430-7400 |
Perry H Beeson Jr Dds Pa Dentist Medicare: Not Enrolled in Medicare Practice Location: 218 Burkemont Ave, Morganton, NC 28655 Phone: 828-437-7070 Fax: 828-437-7950 |
S. Ross Penland, Dmd, Pa-morganton, P.l.l.c Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 110 Juniper St, Suite 200, Morganton, NC 28655 Phone: 828-855-3779 Fax: 828-855-3781 |
Eugene K Olsen Dds Ii Pa Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 218 Burkemont Ave, Morganton, NC 28655 Phone: 828-437-7070 |
Small And Piers Llp Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 110 Juniper St Ste 300, Morganton, NC 28655 Phone: 828-433-1242 Fax: 828-437-3899 |
Morganton Pediatric Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 341 E Parker Rd, Suite A, Morganton, NC 28655 Phone: 828-433-1223 |
Southern Family Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 206 S Sterling St, Morganton, NC 28655 Phone: 828-850-2988 |
Katie Breeze Heald Dds Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 679 W. Fleming Dr., Morganton, NC 28655 Phone: 315-454-6000 |
News Archive
The International Cancer Genome Consortium which includes researchers from 22 countries is mapping the genomes of different types of cancers. A genome is essentially a blueprint of a human's DNA. The genetic data of each individual is different and so is the genetic data of the cancer in the individual. The Australian scientists are sequencing the genomes of people suffering from pancreatic cancer.
Neuromuscular experts with the University of Miami Health System and the Miller School of Medicine will launch a Phase 1/2 clinical trial (NCT04146051) using the CAR-T drug, Descartes-08, to treat patients with generalized myasthenia gravis.
The Norwegian biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax today announced approval by the Norwegian Medicines Agency ('Statens Legemiddelverk') to test a combination of LTX-315 and GV1001 as vaccine therapy in patients with resected tumours. Lytix Biopharma CEO Gunnar Salid states, "We are delighted to announce the approval of our joint study to test a combination of two very interesting experimental drugs.
A study aimed at better understanding why some critically ill patients develop multidrug-resistant infections is underway by researchers at The University of Texas Health Science Center at Houston.
› Verified 3 days ago